Cadre Holdings Discloses $34.5M CEO Expense Reimbursement, Significant Potential Dilution, and Board Changes
CDRE is trading near its 52-week low of $28.22 (3.3% above the low).
Summary
Cadre Holdings' definitive proxy statement reveals over $34.5 million in 'unallocated expense reimbursement' for its CEO, significant potential dilution from equity plans, and material related-party transactions with a CEO-owned entity, alongside changes to its Board of Directors.
Key Events · Corporate Governance and Compliance · CDRE
-
CEO Received Over $34.5 Million in Expense Reimbursement
CEO Warren B. Kanders' 2025 compensation included $34,531,948 for 'unallocated expense reimbursement,' a highly unusual and substantial amount.
-
Significant Potential Dilution from Equity Plans
As of December 31, 2025, 9,683,220 shares remained available for future issuance under equity compensation plans, representing a potential dilution of approximately 22.6% of current outstanding shares.
-
Material Related-Party Transactions Disclosed
The company paid $3 million to Kanders & Company, a firm solely owned by CEO Warren B. Kanders, for support related to two acquisitions in 2025 and 2026.
-
Board of Directors Changes Proposed
Two current directors, Deborah A. DeCotis and Gianmaria C. Delzanno, are not nominated for re-election, while Mary Kissel and former director Nicholas Sokolow are proposed as new board members.
Analysis · CDRE · Industrial Applications And Services
This definitive proxy statement reveals several significant corporate governance and compensation issues that could negatively impact investor sentiment, especially with the stock trading near its 52-week low. The most striking disclosure is the over $34.5 million in 'unallocated expense reimbursement' for CEO Warren B. Kanders in 2025, which is an exceptionally large compensation component. Additionally, the company's equity compensation plans have a substantial 22.6% potential dilution from shares available for future issuance, which could weigh on shareholder value. Material related-party transactions totaling $3 million were paid to Kanders & Company, a firm solely owned by the CEO, for acquisition support. The proposed changes to the Board of Directors, with two current members not standing for re-election and two new/returning nominees, also represent a notable shift in governance. Investors should scrutinize these compensation practices, potential dilution, and related-party dealings.
At the time of this filing, CDRE was trading at $29.15 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $28.22 to $48.76. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.